Huntington’s disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Huntington’s disease (HD) is a fatal neurodegenerative disorder that primarily targets medium spiny neurons, leading to the gradual atrophy of the striatum. The disease affects 4.1-8.4 cases per 100,000 persons in the USA and Europe and typically displays relentless progression of cognitive and motor deficits over a period of 15-20 years. Its most striking clinical feature is the chorea: involuntary complex body movements involving the entire musculature with stereotyped patterns. HD is an autosomal dominant disorder caused by the expansion of an uninterrupted track of CAG repeats within exon 1 of the gene huntingtin (Htt). Htt codes for a soluble and multi-domain protein; the N-terminal fragment interacts with a wide variety of protein partners. Further, Htt contains several consensus sites for posttranslational modifications with significant functional roles, including protease cleavage, SUMOylation, ubiquitination, phosphorylation, palmitoylation, and acetylation. Notably, Htt displays functional pleiotropism, including prominent roles in gene transcription, endocytosis, intracellular trafficking, synaptic spine morphogenesis, apoptosis, and neural development. The abnormal trinucleotide expansion in the Htt gene product triggers a complex combination of gain- and loss-of-function pathological mechanisms that synergistically contribute to disease pathogenesis. Thus, HD pathogenesis may involve the interplay of multiple pathological cascades, including transcriptional dysregulation, neuronal excitotoxicity, impairments in the expression and delivery of neurotrophic factors, mitochondrial dysfunction, aberrant activation of proteases, and protein turnover, including aggregation. Indeed, it is likely that different pathological processes mediating progressive cellular dysfunction and late-onset cell death are operating in discrete brain regions in HD. The enormous strides that have been made in the understanding of the molecular pathogenesis of HD as well as in establishing emerging links between impairments in neural development and neuronal dysfunction have furnished the conceptual underpinnings and the novel molecular targets for devising innovative therapeutic strategies to prevent disease onset and to halt disease progression.

Original languageEnglish (US)
Title of host publicationNeuroscience in the 21st Century
Subtitle of host publicationFrom Basic to Clinical, Second Edition
PublisherSpringer New York
Pages3863-3892
Number of pages30
ISBN (Electronic)9781493934744
ISBN (Print)9781493934737
DOIs
StatePublished - Jan 1 2016

Fingerprint

Huntington Disease
neurodevelopment
pathogenesis
proteinases
neurotrophins
genes
emerging diseases
post-translational modification
neurodegenerative diseases
endocytosis
acetylation
protein metabolism
atrophy
disease course
Peptide Hydrolases
morphogenesis
exons
cell death
Lipoylation
phosphorylation

Keywords

  • BDNF
  • Cannabinoid receptors
  • Epigenetic regulatory processes
  • Gain-of-toxic function mechanism
  • Huntingtin protein
  • Huntington’s disease (HD)
  • Mithochondrial dysfunction
  • Neuronal excitotoxicity
  • NMDA receptor (NMDAR) agonist
  • Protein aggregation
  • Ras/MAPK/ERK1/2
  • Transcriptional dysregulation

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)
  • Agricultural and Biological Sciences(all)

Cite this

Molero, A. E., & Mehler, M. F. (2016). Huntington’s disease. In Neuroscience in the 21st Century: From Basic to Clinical, Second Edition (pp. 3863-3892). Springer New York. https://doi.org/10.1007/978-1-4939-3474-4_113

Huntington’s disease. / Molero, Aldrin E.; Mehler, Mark F.

Neuroscience in the 21st Century: From Basic to Clinical, Second Edition. Springer New York, 2016. p. 3863-3892.

Research output: Chapter in Book/Report/Conference proceedingChapter

Molero, AE & Mehler, MF 2016, Huntington’s disease. in Neuroscience in the 21st Century: From Basic to Clinical, Second Edition. Springer New York, pp. 3863-3892. https://doi.org/10.1007/978-1-4939-3474-4_113
Molero AE, Mehler MF. Huntington’s disease. In Neuroscience in the 21st Century: From Basic to Clinical, Second Edition. Springer New York. 2016. p. 3863-3892 https://doi.org/10.1007/978-1-4939-3474-4_113
Molero, Aldrin E. ; Mehler, Mark F. / Huntington’s disease. Neuroscience in the 21st Century: From Basic to Clinical, Second Edition. Springer New York, 2016. pp. 3863-3892
@inbook{0bcaa0a49f514ba98e494ae4c22fd60d,
title = "Huntington’s disease",
abstract = "Huntington’s disease (HD) is a fatal neurodegenerative disorder that primarily targets medium spiny neurons, leading to the gradual atrophy of the striatum. The disease affects 4.1-8.4 cases per 100,000 persons in the USA and Europe and typically displays relentless progression of cognitive and motor deficits over a period of 15-20 years. Its most striking clinical feature is the chorea: involuntary complex body movements involving the entire musculature with stereotyped patterns. HD is an autosomal dominant disorder caused by the expansion of an uninterrupted track of CAG repeats within exon 1 of the gene huntingtin (Htt). Htt codes for a soluble and multi-domain protein; the N-terminal fragment interacts with a wide variety of protein partners. Further, Htt contains several consensus sites for posttranslational modifications with significant functional roles, including protease cleavage, SUMOylation, ubiquitination, phosphorylation, palmitoylation, and acetylation. Notably, Htt displays functional pleiotropism, including prominent roles in gene transcription, endocytosis, intracellular trafficking, synaptic spine morphogenesis, apoptosis, and neural development. The abnormal trinucleotide expansion in the Htt gene product triggers a complex combination of gain- and loss-of-function pathological mechanisms that synergistically contribute to disease pathogenesis. Thus, HD pathogenesis may involve the interplay of multiple pathological cascades, including transcriptional dysregulation, neuronal excitotoxicity, impairments in the expression and delivery of neurotrophic factors, mitochondrial dysfunction, aberrant activation of proteases, and protein turnover, including aggregation. Indeed, it is likely that different pathological processes mediating progressive cellular dysfunction and late-onset cell death are operating in discrete brain regions in HD. The enormous strides that have been made in the understanding of the molecular pathogenesis of HD as well as in establishing emerging links between impairments in neural development and neuronal dysfunction have furnished the conceptual underpinnings and the novel molecular targets for devising innovative therapeutic strategies to prevent disease onset and to halt disease progression.",
keywords = "BDNF, Cannabinoid receptors, Epigenetic regulatory processes, Gain-of-toxic function mechanism, Huntingtin protein, Huntington’s disease (HD), Mithochondrial dysfunction, Neuronal excitotoxicity, NMDA receptor (NMDAR) agonist, Protein aggregation, Ras/MAPK/ERK1/2, Transcriptional dysregulation",
author = "Molero, {Aldrin E.} and Mehler, {Mark F.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-3474-4_113",
language = "English (US)",
isbn = "9781493934737",
pages = "3863--3892",
booktitle = "Neuroscience in the 21st Century",
publisher = "Springer New York",

}

TY - CHAP

T1 - Huntington’s disease

AU - Molero, Aldrin E.

AU - Mehler, Mark F.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Huntington’s disease (HD) is a fatal neurodegenerative disorder that primarily targets medium spiny neurons, leading to the gradual atrophy of the striatum. The disease affects 4.1-8.4 cases per 100,000 persons in the USA and Europe and typically displays relentless progression of cognitive and motor deficits over a period of 15-20 years. Its most striking clinical feature is the chorea: involuntary complex body movements involving the entire musculature with stereotyped patterns. HD is an autosomal dominant disorder caused by the expansion of an uninterrupted track of CAG repeats within exon 1 of the gene huntingtin (Htt). Htt codes for a soluble and multi-domain protein; the N-terminal fragment interacts with a wide variety of protein partners. Further, Htt contains several consensus sites for posttranslational modifications with significant functional roles, including protease cleavage, SUMOylation, ubiquitination, phosphorylation, palmitoylation, and acetylation. Notably, Htt displays functional pleiotropism, including prominent roles in gene transcription, endocytosis, intracellular trafficking, synaptic spine morphogenesis, apoptosis, and neural development. The abnormal trinucleotide expansion in the Htt gene product triggers a complex combination of gain- and loss-of-function pathological mechanisms that synergistically contribute to disease pathogenesis. Thus, HD pathogenesis may involve the interplay of multiple pathological cascades, including transcriptional dysregulation, neuronal excitotoxicity, impairments in the expression and delivery of neurotrophic factors, mitochondrial dysfunction, aberrant activation of proteases, and protein turnover, including aggregation. Indeed, it is likely that different pathological processes mediating progressive cellular dysfunction and late-onset cell death are operating in discrete brain regions in HD. The enormous strides that have been made in the understanding of the molecular pathogenesis of HD as well as in establishing emerging links between impairments in neural development and neuronal dysfunction have furnished the conceptual underpinnings and the novel molecular targets for devising innovative therapeutic strategies to prevent disease onset and to halt disease progression.

AB - Huntington’s disease (HD) is a fatal neurodegenerative disorder that primarily targets medium spiny neurons, leading to the gradual atrophy of the striatum. The disease affects 4.1-8.4 cases per 100,000 persons in the USA and Europe and typically displays relentless progression of cognitive and motor deficits over a period of 15-20 years. Its most striking clinical feature is the chorea: involuntary complex body movements involving the entire musculature with stereotyped patterns. HD is an autosomal dominant disorder caused by the expansion of an uninterrupted track of CAG repeats within exon 1 of the gene huntingtin (Htt). Htt codes for a soluble and multi-domain protein; the N-terminal fragment interacts with a wide variety of protein partners. Further, Htt contains several consensus sites for posttranslational modifications with significant functional roles, including protease cleavage, SUMOylation, ubiquitination, phosphorylation, palmitoylation, and acetylation. Notably, Htt displays functional pleiotropism, including prominent roles in gene transcription, endocytosis, intracellular trafficking, synaptic spine morphogenesis, apoptosis, and neural development. The abnormal trinucleotide expansion in the Htt gene product triggers a complex combination of gain- and loss-of-function pathological mechanisms that synergistically contribute to disease pathogenesis. Thus, HD pathogenesis may involve the interplay of multiple pathological cascades, including transcriptional dysregulation, neuronal excitotoxicity, impairments in the expression and delivery of neurotrophic factors, mitochondrial dysfunction, aberrant activation of proteases, and protein turnover, including aggregation. Indeed, it is likely that different pathological processes mediating progressive cellular dysfunction and late-onset cell death are operating in discrete brain regions in HD. The enormous strides that have been made in the understanding of the molecular pathogenesis of HD as well as in establishing emerging links between impairments in neural development and neuronal dysfunction have furnished the conceptual underpinnings and the novel molecular targets for devising innovative therapeutic strategies to prevent disease onset and to halt disease progression.

KW - BDNF

KW - Cannabinoid receptors

KW - Epigenetic regulatory processes

KW - Gain-of-toxic function mechanism

KW - Huntingtin protein

KW - Huntington’s disease (HD)

KW - Mithochondrial dysfunction

KW - Neuronal excitotoxicity

KW - NMDA receptor (NMDAR) agonist

KW - Protein aggregation

KW - Ras/MAPK/ERK1/2

KW - Transcriptional dysregulation

UR - http://www.scopus.com/inward/record.url?scp=85018914388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018914388&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-3474-4_113

DO - 10.1007/978-1-4939-3474-4_113

M3 - Chapter

AN - SCOPUS:85018914388

SN - 9781493934737

SP - 3863

EP - 3892

BT - Neuroscience in the 21st Century

PB - Springer New York

ER -